StockData
Centene Corp logo

Centene Corp (CNC) stock

CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/307% above fair value
$72.55−2.22 (-2.97%)

Close on Nov 17, 2026Market cap $35.92BP/E 24.8Yield –

Centene operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Centene's operating cash flow for the twelve months ending Sep 30, 2026 was $4.72B, up 16.2% year over year. For fiscal 2025 it was $5.09B, up 3203.9% from the year before. Over ten years it grew 22.7% a year on average. The highest annual figure on record is $8.05B in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.09B+3203.9%
FY2024Dec 31, 2024$154.00M-98.1%
FY2023Dec 31, 2023$8.05B+28.6%
FY2022Dec 31, 2022$6.26B+48.9%
FY2021Dec 31, 2021$4.21B-23.6%
FY2020Dec 31, 2020$5.50B+271.1%
FY2019Dec 31, 2019$1.48B+20.2%
FY2018Dec 31, 2018$1.23B-17.1%
FY2017Dec 31, 2017$1.49B-19.6%
FY2016Dec 31, 2016$1.85B+181.3%
FY2015Dec 31, 2015$658.00M-46.2%
FY2014Dec 31, 2014$1.22B+220.2%
FY2013Dec 31, 2013$382.00M+36.9%
FY2012Dec 31, 2012$279.00M+6.6%
FY2011Dec 31, 2011$261.70M+54.9%
FY2010Dec 31, 2010$168.93M-31.9%
FY2009Dec 31, 2009$248.20M+11.8%
FY2008Dec 31, 2008$221.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.67B-370.6%
Q2 FY2026Jun 30, 2026$3.59B+101.1%
Q1 FY2026Mar 31, 2026$4.37B+189.1%
Q4 FY2025Dec 31, 2025$437.00M–
Q3 FY2025Sep 30, 2025$1.36B–
Q2 FY2025Jun 30, 2025$1.79B-17.9%
Q1 FY2025Mar 31, 2025$1.51B–
Q4 FY2024Dec 31, 2024-$587.00M-370.5%
Q3 FY2024Sep 30, 2024-$978.00M-195.8%
Q2 FY2024Jun 30, 2024$2.18B-14.6%
Q1 FY2024Mar 31, 2024-$456.00M-110.7%
Q4 FY2023Dec 31, 2023$217.00M–
Q3 FY2023Sep 30, 2023$1.02B-69.4%
Q2 FY2023Jun 30, 2023$2.55B-24.1%
Q1 FY2023Mar 31, 2023$4.27B+270.9%
Q4 FY2022Dec 31, 2022-$1.58B-333.5%
Q3 FY2022Sep 30, 2022$3.33B+84.9%
Q2 FY2022Jun 30, 2022$3.35B+99.1%
Q1 FY2022Mar 31, 2022$1.15B+2576.7%
Q4 FY2021Dec 31, 2021$675.00M-77.4%
Q3 FY2021Sep 30, 2021$1.80B–
Q2 FY2021Jun 30, 2021$1.69B-54.6%
Q1 FY2021Mar 31, 2021$43.00M–
Q4 FY2020Dec 31, 2020$2.98B–
Q3 FY2020Sep 30, 2020-$952.00M–
Q2 FY2020Jun 30, 2020$3.71B+305.0%
Q1 FY2020Mar 31, 2020-$240.00M-118.2%
Q4 FY2019Dec 31, 2019-$651.00M–
Q3 FY2019Sep 30, 2019-$99.00M-118.1%
Q2 FY2019Jun 30, 2019$917.00M–
Q1 FY2019Mar 31, 2019$1.32B-28.7%
Q4 FY2018Dec 31, 2018-$634.00M-240.9%
Q3 FY2018Sep 30, 2018$548.00M+464.9%
Q2 FY2018Jun 30, 2018-$526.00M–
Q1 FY2018Mar 31, 2018$1.85B+47.9%
Q4 FY2017Dec 31, 2017$450.00M-71.7%
Q3 FY2017Sep 30, 2017$97.00M–
Q2 FY2017Jun 30, 2017-$306.00M–
Q1 FY2017Mar 31, 2017$1.25B–
Q4 FY2016Dec 31, 2016$1.59B–

More Centene figures

See a number that looks wrong?